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Summary To ascertain whether fatigue perception is linked to exertion dyspnea
and/or to an impaired cardiorespiratory response during walk, 11 patients (8
females, age range 21–46 years) with multiple sclerosis (MS) and mild disability
underwent the 6-min walk test. Ten healthy subjects (7 females, age range 25–49
years) were studied, as a control group. Patients did not differ from controls in
spirometry, lung volumes and respiratory muscle strength. There was a significant
difference in walk distance between patients and controls (Po0:001), but not in
dyspnea perception. In patients, the walk distance significantly related to disability
score (Po0:01), but not to fatigue. Compared to controls, patients had a significant
decrease in oxygen pulse during walk (Po0:05) and a significant increase in the
ventilatory equivalent of CO2 both at baseline and during walk (Po0:05). The
relative contribution of both the tidal volume and of the ratio of inspiratory to total
breathing cycle duration to the increase in minute ventilation during walk was
significantly less in patients, as compared to controls (Po0:05). We conclude that in
MS patients with mild disability, fatigue and exertion dyspnea are different
sensations without any link and a peripheral limitation during walk can occur.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Multiple sclerosis (MS) is a central nervous system
disorder characterized by the presence of areas of
demyelination, which causes nerve conduction
disturbances. Neurological deficiencies have vari-
able course and after relapses, episodes of remis-
sion typically occur. Irrespective of clinical phase of
the disease, fatigue is the most common symptom
and can profoundly limit the daily living activities
of MS patients.1
Although central nervous abnormalities play a
key role in the pathogenesis of fatiguing exercise in
MS,2 peripheral factors may also be involved. A
poor tolerance to treadmill exercise has been
related to an increased energy cost,3 though energy
cost of an incremental exercise on cycle ergometer
was not increased in MS patients with mild
disability and poor training condition.4 Additionally,
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exercise tolerance on arm ergometer was related
to respiratory muscle dysfunction in MS patients
with a wide range of disability degree.5
Clinical exercise testing with cycle or arm
ergometer or treadmill using either maximal or
sub-maximal protocols may be unfamiliar to many
patients and extrapolation of such data to everyday
activity is not always appropriate. Furthermore,
patients may be unable to pace themselves on a
treadmill, even at low speed, and treadmill test
results can underestimate the walking performance
assessed by self-paced corridor tests.6,7 Among the
modalities available for the objective evaluation of
functional exercise capacity, the self-paced 6-min
walk test (6 MWT) is an easy to administer form
of exercise for patients and may better reflect
the functional exercise level for daily physical
activities.8
In this study, we assessed the perceived impact of
fatigue on physical, cognitive and psychosocial
functioning in MS patients with mild degree of
disability and normal cardiorespiratory function.
Moreover, to ascertain whether fatigue perception
is linked to dyspnea on exertion and/or to impair-
ment in cardiorespiratory response during walk, we
tested these patients with the 6MWT.
Methods
Subjects
We studied 11 patients with MS diagnosed according
to the Poser’s criteria.9 All patients did not report
any history of cardiac or pulmonary disease and had
normal physical examination, chest radiography
and resting electrocardiogram. Four patients out of
11 reported a history of mild smoking, since they
were smoking less than 10 cigarettes per day.
Moreover, patients were not anaemic or hypoka-
lemic and were clinically stable for at least 4
weeks. At the time of the study, seven patients
underwent treatment with interferon beta. No
patient was currently in steroid therapy or had
been treated with steroids for at least 2 months
preceding the study. As a control group, we studied
10 healthy subjects recruited from the medical
staff. All subjects gave informed consent to
participate in the study.
Clinical assessment
The neurological impairment and the disability
degree were assessed by the Expanded Disability
Status Scale (EDSS).10 The EDSS provides a score
ranging from zero, indicating normal neurological
findings, to 10, indicating death from MS. The EDSS
score was assigned without knowledge of the
subject’s pulmonary and walking results. We only
included patients with an EDSS score less than 4 and
pyramidal deficiency.
The subjects’ perceived impact of fatigue was
assessed in MS patients and in healthy controls by
the 0–84 Modified Fatigue Impact Scale (MFIS).11
The MFIS is a structured, self-report, 21 items-
questionnaire which provides an assessment of the
effects of fatigue in terms of physical, cognitive,
and psychosocial functioning. All items are scaled
so that higher scores indicate a greater impact of
fatigue on a person’s activities. The fatigue was
defined as a subjective lack of physical and/or
mental energy that is perceived by the individual to
interfere with usual and desired activities.11
Lung function and respiratory muscle
strength test
Pulmonary function was measured by a flow-sensing
spirometer and a body pletismograph connected to
a computer for data analysis (Vmax 22 and 6200,
Sensor Medics, Yorba Linda, US). Baseline total lung
capacity (TLC), forced expiratory volume in the
first second (FEV1), and FEV1/VC ratio were
recorded. Carbon monoxide transfer capacity
(TLCo) was also measured by the single breath
method. All these variables are expressed as
percent of predicted value.12,13
PEmax and PImax were performed against a
valve, which could be closed by turning a tap.14
PEmax and PImax were measured in cm H2O from
TLC and RV, respectively. The highest recorded
pressures maintained for 1 s were used for analysis.
Six-minute walk test
Patients and controls performed two 6MWTs,
according to a standard protocol.15 The 6MWTs
were symptom limited, so patients were allowed to
stop if necessary, though they were instructed to
resume walking as soon as possible. The second
6MWT was performed in the same manner as the
first, following a rest of at least 60min. The walk
distance was recorded in meters and expressed as
percent of predicted value.15 Results from the
second walk only were used for analysis to allow for
any learning effect.16
Before and immediately after 6MWT, patients
and controls rated the magnitude of their per-
ceived breathlessness on an interval scale, which
was a 100-mm horizontal visual analogue scale.17
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The visual analogue scale (VAS) consisted of a
horizontal ruler without any mark on the patient’s
side with the words ‘‘not at all breathless’’ and
‘‘extremely breathless’’ on the left and right end,
respectively. Breathlessness perception ratings
were expressed in mm from 0 to 100 and
corresponded to the distance of the marker from
the left end of the VAS.
Oxygen consumption, CO2 production,
ventilation, and heart rate
The oxygen uptake (VO2, in ml/min), the CO2
output (VCO2, in ml/min), the tidal volume (VT; in
l), the respiratory rate (RR, in bpm) and the heart
rate (HR, in bpm) were continuously monitored
from 5min before the walk until the test comple-
tion, as well as 5min after completion, or until
recovery of the baseline value. The derived
parameters were the minute ventilation (VE; in l/
min), the ratio of inspiratory to total breathing
cycle duration (TI=TTOT), the mean inspiratory flow
(VT=TI; in ml/s), the end-tidal pressure of O2
(PetO2, in mmHg) and CO2 (PetCO2, in mmHg),
the oxygen pulse (VO2/HR, in ml/bpm) and the
ventilatory equivalent of CO2 (VE/VCO2).
A telemetric portable system (Cosmed, K4,
Rome, Italy) was utilized for VO2, VCO2, VE and
HR measurements. The K4 system consisted of
facemask, HR chest strip, battery and transmitting
unit (containing the O2 and CO2 gas analyzers), and
a receiving unit connected to a computer. The
transmitting unit with battery pack and facemask
with tubing (total weight 0.8 kg) was attached to
the individual with a harness. The facemask
contained a turbine for measurement of ventilation
as well as capillary gas sampling port within the
turbine’s housing. The expired gas was sampled at a
rate proportional to ventilation, by way of a
dynamic sampling pump, through a special sample
capillary of polymer Nafion (Perma Pure) and into a
microchamber containing the O2 (polarographic)
and CO2 (infrared) electrodes. O2 and CO2 analyzers
were thermostated and compensated for the
variations of barometric pressure and humidity of
the environment. VO2 (STDP), VCO2 (STDP) and VEðBTPSÞ;
were calculated every 15 s. Calibration of the
turbine and a two-point calibration of the gas
analysers were performed before each test.
Statistical analysis
Values are presented as mean7standard deviation
(SD), unless otherwise specified. The unpaired
t-test, the Mann–Whitney rank sum test and the
w2 test were used for comparison between MS
patients and controls, when appropriate. Analysis
of variance for repeated measures and post hoc
Bonferroni test were used to evaluate the differ-
ence between resting and exercise values. Resting
and exercise values of VT; RR, TI/TTOT, and VT=TI
were plotted against the corresponding ones of VE
and were fitted according to least-squares linear
regression analysis. In order to linearize the
relationship between these variables, VE was log-
transformed before analysis. Correlations in the
patient group were estimated by the Spearman’s
rank correlation coefficient (rs). A P-value p0.05
was taken as significant.
Results
Personal details and pulmonary function test results
of patients and healthy subjects are reported in
Table 1. There was no significant difference
between patients and healthy subjects, when age,
sex, BMI, lung function and respiratory muscle
strength were considered. The duration of disease
was 9 years75 (range 1–17 years) and the median
(range) of EDSS score was 2.5 (1–3.5). The most
common pyramidal dysfunctions consisted in mildly
increased muscle tone of one or two limbs,
increased tendon reflexes, extensor plantar re-
sponse and lower limb weakness and were not so
disabling to request any walking aids to patients. In
MS patients and healthy subjects, the medians
(range) of MFIS scores were respectively 18 (2–59)
and 4 (0–10) (Po0:01). There was no difference in
MFIS score between treated and non-treated
patients with interferon beta.
All MS patients were able to complete a 6MWT
without any stop. There was a significant mean
difference of 193m in walk distance between
patients and healthy volunteers (Table 1;
Po0:001). In MS patients, the walk distance,
expressed as percent of predicted value, was
significantly related to EDSS score value
(rs ¼ 0:82; Po0:01) (Fig. 1), but not to MFIS
score. Mean VAS values after walk in patients and
healthy subjects were not statistically different
(30mm724 and 17mm79, respectively). In pa-
tients no correlation was found between VAS values
after walk and EDSS and MFIS scores.
Resting PetO2 and PetCO2 values in MS patients
and healthy subjects, were 112mmHg73 vs.
110mmHg74 (P¼ ns) and 33mmHg74 vs.
36mmHg73 (Po0:05), respectively. These values
slightly, but significantly changed during the walk
and reached a plateau phase at 2ndmin of walk. At
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6thmin of walk in patients and controls, they were
respectively 104mmHg75 (Po0:01 vs. baseline)
and 99mmHg77 (Po0:01 vs. baseline) and
37mmHg74 (Po0:01 vs. baseline) and
42mmHg74 (Po0:01 vs. baseline). VO2, VCO2, VE;
and HR values at rest and during walk are shown in
Table 2. At baseline, values in MS patients and
controls were not different. During the 6MWT, both
VO2 and VCO2 values increased, threefold in MS
patients and fourfold in healthy subjects, whereas
VE increased twofold and threefold, respectively
(Table 2). At the plateau phase VO2, VCO2, VE; and
HR values were significantly lower in MS patients
when compared to those of healthy volunteers
(Table 2). Between groups difference was approxi-
mately 400ml for VO2 and VCO2 and 8 l/min in VE:
The increase in VO2/HR during walk in MS patients
was significantly lower than in controls (Fig. 2).
Moreover, patients had a significant increase in VE/
VCO2 both at baseline and during the 6MWT, when
compared to healthy volunteers (Fig. 2).
Mean resting values of RR (20 bpm73 vs.
19 bpm73), VT (0.6 l70.2 vs. 0.6 l70.2), VT=TI
(464ml/s7114 vs. 502ml/s7193), and TI/TTOT
(0.4070.03 vs. 0.3870.03) in MS patients and
controls were similar. However, their relative
contribution to the increase of VE during the walk
was different. The slopes of VT/logVE and TI/TTOT/
logVE were significantly less steep in MS patients
than in controls (0:8770:19 vs. 1.6570.17; Po0:05
and 0.1170.02 vs. 0.1870.01; Po0:05). The
difference in slopes of RR/log VE and VT/TI/logVE
were not statistically different (2275 vs. 1574 and
1356737 vs. 17187185) (Fig. 3).
Discussion
Our results confirmed that MS patients even with a
mild degree of disability, had a higher perception of
fatigue in comparison to a matched group of
healthy subjects. As expected, MS patients covered
a less walk distance, which was strictly related to
the disability degree assessed by EDSS score.
Additionally, we provide the evidence that during
the self-paced 6MWT, MS patients with normal
cardiorespiratory function at rest, had a reduced
oxygen pulse and an impaired breathing pattern
during the walk and an increased ventilatory
equivalent of CO2 both at rest and during the walk,
as compared to healthy volunteers.
Most patients affected by MS report fatigue as
one of their worst problem.11,18 Fatigue can
exacerbate physical impairment and disability and
is intimately related to the individual’s sense of
control over the illness and overall mental health.19
Despite the well-known poor tolerance to exercise
in MS, the relationship between exertion dyspnea
and fatigue in patients with MS has been little
investigated. In this study, we found that MS
patients who had normal lung function and respira-
tory muscle strength and mild disability, com-
plained of fatigue more than controls and that
fatigue was related neither to the physical dis-
ability nor to dyspnea on exertion. This supports
the view that both fatigue and dyspnea perception
have different underlying mechanisms. Our findings
are consistent with previous results,11 which
showed that fatigue impact could not be predicted
by the clinical measure of neurological impairment.
Previously, Olgiati and co-workers3 reported that
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Figure 1 Relationship between walk distance, expressed
as percent of predicted value, and the disability level,
evaluated by an EDSS score, of 11 MS patients.
rs¼ Spearman’s rank correlation coefficient.
Table 1 Characteristics of 11 patients with multi-
ple sclerosis and 10 healthy subjects.
MS
patients
Healthy
subjects
Age (years) 3277 3378
Gender (F/M) 8/3 7/3
Smokers (Y/N) 4/7 0/10*
BMI (kg/m2) 2274 2172
FEV1 (% of pred) 90716 104719
TLC (% of pred) 108710 107716
TLCO (% of pred) 77720 82710
PImax (cmH2O) 77723 88732
PEmax (cmH2O) 106735 115726
6MWT distance (m) 384742 577756*
6MWT distance (% of pred) 5578 8077*
Values are expressed as mean7SD; Po0:05:
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dyspnea in MS patients was higher than in healthy
controls and was related to the energy cost of
exercise, but not to fatigue. However, patients
were impaired in lung volumes and respiratory
muscle strength and did not score exertional
dyspnea, which was instead extrapolated by re-
spiratory parameters.
In this study, we found that the walk distance
which can be considered as a measure of muscle
limb fatigability, covered by MS patients was
significantly reduced and was not related to the
sense of fatigue. A reduced walk distance was
expected, since patients had mild spasticity and
lower limbs weakness. We found that walk dis-
tance, expressed as percent of predicted value,
was strictly related to the degree of disability, as
evaluated by the EDSS score. Previous studies on
exercise tolerance in MS patients3–5 did not report
any relationship between disability degree and
exercise capacity. This discrepancy can be ex-
plained because, unlike our study protocol, in
these studies patients performed an incremental
exercise testing. Furthermore, a significant rela-
tionship between the disability level, assessed by
the EDSS score, and the endurance time of
inspiratory muscles was found in MS patients with
respiratory muscle weakness.5 Similarly, in MS
patients with a wide range of respiratory muscle
weakness,20,21 the EDSS score was inversely related
to maximal voluntary ventilation, which can be
considered as an endurance test of respiratory
muscles when lung volumes and flow-related
pressure are in the normal range. In absence of
heart and lung impairment, even the 6MWT
can be considered as an endurance, submaximal
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Table 2 Mean values7SD at baseline and during the 6MWT of VO2, VCO2, VE and HR in 11 patients with multiple
sclerosis (MS) and in 10 healthy subjects (HS).
Baseline 1st min 2nd min 3rd min 4th min 5th min 6th min
VO2 MS 237774 4007136 6067170
n,w 6857137n,w 6857134n,w 6717130n,w 6887130n,w
(ml/min) HS 252767 5527256 9467414n 11117412n 10997432n 10867423n 10357321n
VCO2 MS 213776 3657125
n,w 4757141n,w 5617113n,w 5837111n,w 5947112n,w 6117114n,w
(ml/min) HS 238775 5197183 8097293n 10107382n 10627430n 10927435n 10417300n
VE MS 1172 1674 1975
n 2174n,w 2274n,w 2274n,w 2374n,w
(l/min) HS 1073 1875 2477n 2878n 2979n 3079n 3077n
HR MS 86710 101714 106713n,w 108714n,w 107712n,w 108715n,w 111720n
(bpm) HS 82710 111715n 120713n 123712n 124713n 125714n 126713n
nPo0:05 vs. baseline.
wPo0:05 vs. healthy subjects.
0 1 2 3 4 5 6
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Figure 2 (Upper panel) Mean and standard deviation
values of oxygen pulse (VO2/HR) in 11 MS patients
(continuous line) and 10 healthy subjects (interrupted
line) at baseline and during the 6MWT. (Lower panel)
Mean and standard deviation values of ventilatory
equivalent of carbon dioxide (VE/VCO2) in 11 MS patients
(continuous line) and 10 healthy subjects (interrupted
line) at baseline and during the 6MWT.
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exercise test of limbs muscles, since it demands the
ability to sustain the exercise, rather than the
capacity for maximum exercise. Taken together
these findings suggest that the disability of MS
patients is inversely related to the skeletal muscles
endurance.
We showed that oxygen pulse in MS patients
with normal cardiorespiratory function is reduced
during self-paced walking. Previous studies showed
that in MS patients, oxygen pulse is reduced during
both incremental exercises on treadmill3 or on
cycle-ergometer.4 Taken together these findings
suggest that MS patients have a reduced cardiovas-
cular fitness, which is evident even during mild
intensity exercise. Oxygen pulse represents the
volume of oxygen extracted by the tissues per
heartbeat; hence a reduced ability of muscles in
oxygen extraction, which is typical of de-condi-
tioning, may occur in MS patients. Most MS patients
lead a quite sedentary life and in order to
reduce the onset of fatigue, they limit walking
and daily living activities, which in turn may lead to
further deterioration of muscle training state.
Besides de-conditioning, cardiovascular autonomic
dysfunction could also play a role in oxygen pulse
reduction. An impaired response of heart rate and
blood pressure to deep breathing, Valsalva man-
oeuvre and arm exercise was found in MS patients22
and this autonomic dysfunction correlated with
fatigue.23
MS patients had a significant increase in ventila-
tory equivalent of CO2 both at rest and during walk
that indicates an inefficient ventilation. This could
either be due to an increased dead space leading to
ventilation-perfusion mismatch or to a relative
alveolar hyperventilation, caused by hypoxemia or
by an increase in central drive or receptor stimula-
tion.24 A ventilation-perfusion mismatch as a cause
of the increased ventilatory equivalent of CO2 is
unlikely since our patients had normal lung function
and a reduced PetCO2 levels both at rest and during
walk, suggesting alveolar hyperventilation. Since
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Figure 3 (Upper left panel) Relationship between respiratory rate (RR) and log minute ventilation (VE) in 11 MS
patients (closed circles) and in 10 healthy subjects (open circles) during the 6MWT. The continuous line and the
interrupted line are the linear regression lines, respectively, in MS patients and healthy subjects; P-value refers to the
significance between regression line slopes. (Upper right panel) Relationship between tidal volume (VT) and log minute
ventilation (VE) in 11 MS patients (closed circles) and in 10 healthy subjects (open circles) during the 6MWT. The
continuous line and the interrupted line are the linear regression lines, respectively, in MS patients and healthy
subjects; P-value refers to the significance between regression line slopes. (Lower left panel) Relationship between the
mean inspiratory flow (VT/TI), and log minute ventilation (VE) in 11 MS patients (closed circles) and in 10 healthy
subjects (open circles) during the 6MWT. The continuous line and the interrupted line are the linear regression lines,
respectively, in MS patients and healthy subjects; P-value refers to the significance between regression line slopes.
(Lower right panel) Relationship between the ratio of inspiratory to total breathing cycle duration (TI/TTOT) and log
minute ventilation (VE) in 11 MS patients (closed circles) and in 10 healthy subjects (open circles) during the 6MWT. The
continuous line and the interrupted line are the linear regression lines, respectively, in MS patients and healthy
subjects; P-value refers to the significance between regression line slopes.
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resting PetO2 values were normal, hypoxemia as a
possible cause of alveolar hyperventilation could be
ruled out. Moreover, since the mean inspiratory
flow, which is considered as an indirect measure of
central drive, did not differ between MS patients
and control subjects both at rest and during walk,
an increase in chemoreceptor and mechanorecep-
tor activity may likely be the most important
factor, which affects the control of breathing in
these patients. Indeed, an increase in neural
afferent information has been shown to impair
the ventilatory control in neuromuscular disease.25
Furthermore, anxiety, often associated to MS,26,27
might be a complementary factor in inducing
alveolar hyperventilation.
We found that in MS patients the breathing
pattern was normal at rest but impaired during
the walk. MS patients had a lower walking speed
than that of controls and this could explain the
changes of breathing pattern during the walk.
However, the relative contribution of the tidal
volume and the TI/TTOT to the walk-increased
minute ventilation was significantly less in MS
patients, as compared to healthy subjects. More-
over, the breathing rate recorded during the walk
in MS patients, was higher although not signifi-
cantly, than in controls when plotted to the same
level of ventilation. These findings suggest that MS
patients had abnormally shallow rapid breathing
during the walk. Interestingly, a rapid shallow
pattern of breathing has been found at rest in MS
patients with moderate to severe respiratory
muscle weakness.21,28 Furthermore, studies in MS
patients demonstrated an intramuscular compo-
nent to fatigue, as a result of impaired excitation–
contraction coupling and abnormal muscle meta-
bolism.29 Studies in healthy subjects showed that
induction of respiratory muscle fatigue during
strong exercise can result in a rapid shallow pattern
of breathing,30,31 aimed to minimize respiratory
sensation.32 It seems likely that mild forms of
exercise related to the daily activities, such as
walking may be fatiguing efforts to the respiratory
muscles of mild MS patients and may induce an
impairment in breathing pattern.
In summary, we showed that in MS patients with a
low degree of disability, fatigue and exertional
dyspnea are different subjective experiences with-
out any link. Our results suggest that patients with
MS had a peripheral limitation in walk perfor-
mance, as shown by the decreased oxygen pulse
and the impaired breathing pattern. We would
encourage the use of the 6MWT as a routine
assessment of mildly disabled MS patients with
motor deficiency, since the degree of disability is
strictly related to the walk distance.
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